ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000228661.1	Ponatinib	Pancreatic adenocarcinoma	0.002355264	Resistant
ENSG00000228661.1	Ponatinib	Cervical squamouscell carcinoma and endocervical adenocarcinoma	0.02256056	Sensitive